• SPX
  • $5,893.62
  • 0.39 %
  • $23.00
  • DJI
  • $43,389.60
  • -0.13 %
  • -$55.39
  • N225
  • $38,514.24
  • 0.77 %
  • $293.61
  • FTSE
  • $8,109.32
  • 0.57 %
  • $45.71
  • IXIC
  • $18,791.81
  • 0.6 %
  • $111.69
Chimerix, Inc. (CMRX) Competitors

Chimerix, Inc. (CMRX) Competitors

NASDAQ Currency in USD Disclaimer

Stock Price

$0.89

$0.03

(3.2%)

Day's range
$0.85
Day's range
$0.92

Chimerix, Inc. Competitors

Symbol Company Share Price Market Cap P/E Ratio Employee Count Revenue
ACHL
Achilles Therapeutics plc $1.05 $37.06 M -0.56 204 $0
ASMB
Assembly Biosciences, Inc. $15.68 $78.73 M -1.35 65 $7.16 M
CTMX
CytomX Therapeutics, Inc. $0.86 $127.79 M 7.81 120 $101.21 M
DAWN
Day One Biopharmaceuticals, Inc. $13.00 $1.12 B -5.11 174 $0
MREO
Mereo BioPharma Group plc $3.32 $479.72 M -22.8 33 $10.00 M
NLTX
Neoleukin Therapeutics, Inc. $3.49 $8.20 M -0.28 7 $0
NXTC
NextCure, Inc. $1.29 $38.88 M -0.61 82 $0
SPRO
Spero Therapeutics, Inc. $1.14 $75.85 M 3.19 46 $96.74 M
TERN
Terns Pharmaceuticals, Inc. $5.69 $462.44 M -5.67 66 $0
TIL
Instil Bio, Inc. $24.86 $69.59 M -0.56 49 $0
XFOR
X4 Pharmaceuticals, Inc. $0.38 $169.62 M -1.51 127 $0
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.